CRISPR Therapeutics AG (CRSP)

55.18 -1.59 (-2.80%) USD  |  NASDAQ  |  Feb 25, 16:00
55.09 -0.09 (-0.16%) After-Hours: 20:00
More

CRISPR Therapeutics Excess Tax Benefit from Stock Compensation (Quarterly)

Excess Tax Benefit from Stock Compensation (Quarterly) Chart

View Excess Tax Benefit from Stock Compensation (Quarterly) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Excess Tax Benefit from Stock Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years

View Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks

View Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. --
Beam Therapeutics, Inc. --
Novartis AG --
Recursion Pharmaceuticals, Inc. --
EvoNext Holdings SA --